| L04AJ09 |
L04AJ09 Danicopan |
| L04AJ10 |
L04AJ10 Vilobelimab |
| L04AJ11 |
L04AJ11 Pozelimab |
| L04AK |
L04AK Dihydroorotate dehydrogenase (DHODH) inhibitors |
| L04AK01 |
L04AK01 Leflunomide |
| L04AK02 |
L04AK02 Teriflunomide |
| L04AL |
L04AL Neonatal fragment crystallizable receptor (FcRn) inhibitors |
| L04AL01 |
L04AL01 Efgartigimod alfa |
| L04AL02 |
L04AL02 Rozanolixizumab |
| L04AL03 |
L04AL03 Nipocalimab |
| L04AX |
L04AX Other immunosuppressants |
| L04AX01 |
L04AX01 Azathioprine |
| L04AX02 |
L04AX02 Thalidomide |
| L04AX03 |
L04AX03 Methotrexate |
| L04AX04 |
L04AX04 Lenalidomide |
| L04AX05 |
L04AX05 Pirfenidone |
| L04AX06 |
L04AX06 Pomalidomide |
| L04AX07 |
L04AX07 Dimethyl fumarate |
| L04AX08 |
L04AX08 Darvadstrocel |
| L04AX09 |
L04AX09 Diroximel fumarate |
| L04AX10 |
L04AX10 Tegomil fumarate |
| L04AX11 |
L04AX11 Monomethyl fumarate |
| M |
M الجهاز العضلي الهيكلي |
| M01 |
M01 Anti-inflammatory and antirheumatic products |
| M01A |
M01A Anti-inflammatory and antirheumatic products, non-steroids |
| M01AA |
M01AA Butylpyrazolidines |
| M01AA01 |
M01AA01 Phenylbutazone |
| M01AA02 |
M01AA02 Mofebutazone |
| M01AA03 |
M01AA03 Oxyphenbutazone |
| M01AA05 |
M01AA05 Clofezone |